Background Few studies have investigated the additional healthcare costs of recurrent C.
difficile infection (CDI). Aim To quantify inpatient treatment costs for CDI and length of stay …

Background The management of Clostridium difficile infection (CDI) among hospitalized
patients is costly, and ongoing payment reform is compelling hospitals to reduce its burden …

Objective. To determine the attributable inpatient costs of recurrent Clostridium difficile
infections (CDIs) Design. Retrospective cohort study. Setting. Academic, urban, tertiary care …

Background The economic burden of Clostridium difficile infection (CDI), the leading cause
of nosocomial infectious diarrhea, is not well understood. The objective of this study was to …

BACKGROUND Clostridium difficile infection (CDI) is the most common healthcare-
associated infection and is associated with considerable morbidity. Recurrent CDI is a key …

Abstract Background. The incidence of Clostridium difficile–associated disease (CDAD) is
increasing. There are few data on the short-term and long-term attributable costs of CDAD …

Objectives Accurate and sufficiently detailed data on the economic burden of Clostridium
difficile infection (CDI) are lacking. We performed a micro-costing study to determine the …

BACKGROUNDHigh-quality cost estimates for hospital-acquired Clostridium difficile
infection (CDI) are vital evidence for healthcare policy and decision-making. OBJECTIVETo …

In most healthcare systems, third-party payers fund the costs for patients admitted to hospital
for Clostridium difficile infection (CDI) whereas, for CDI cases arising as complications of …

BACKGROUNDConsiderable efforts have been dedicated to developing strategies to
prevent and treat recurrent Clostridium difficile infection (rCDI); however, evidence of the …